Convatec Group PLC

Major Shareholding Notification • May 8, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3574N

ConvaTec Group PLC

08 May 2018

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:			CONVATEC GROUP PLC (LEI: 213800LS272L4FIDOH92)
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name			NORDIC CAPITAL VI LIMITED NORDIC CAPITAL VII LIMITED
City and country of registered office (if applicable)			26 Esplanade, St Helier, Jersey JE2 3QA
4. Full name of shareholder(s) (if different from 3.)v
Name			CIDRON HEALTHCARE TOPCO LIMITED CIDRON HEALTHCARE CO-INVEST LIMITED CIDRON HEALTHCARE CO-INVEST II LIMITED
City and country of registered office (if applicable)			26 Esplanade, St Helier, Jersey JE2 3QA
5. Date on which the threshold was crossed or reachedvi:			08/05/2018
6. Date on which issuer notified (DD/MM/YYYY):			08/05/2018
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached	0%	N/A		0%	1,951,850,599
Position of previous notification (if applicable)	7.34%	N/A		7.34%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rightsix					% of voting rights
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)			Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
ORDINARY SHARES OF £0.10 EACH GB00BD3VFW73		0		0			0		0
SUBTOTAL 8. A		0					0%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument		Expiration datex	Exercise/ Conversion Periodxi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
N/A
			SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument	Expiration datex		Exercise/ Conversion Period xi		Physical or cash settlementxii			Number of voting rights	% of voting rights
N/A
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)				X
Namexv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
See chain of control described in box 11 (Additional Information) below. No entity in the chain of controlled undertakings now holds shares in the Issuer.	N/A	N/A	N/A
10. In case of proxy voting, please identify:
Name of the proxy holder		N/A
The number and % of voting rights held		N/A
The date until which the voting rights will be held		N/A
11. Additional informationxvi
Nordic Capital VI Limited is the General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. (Fund VI) and is responsible for managing Fund VI. Nordic Capital VII Limited is the General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. (Fund VII) and is responsible for managing Fund VII. Fund VI and Fund VII hold shares in Cidron Healthcare Topco Limited (Topco). Topco in turn holds one management share in each of Cidron Healthcare Co-invest Limited and Cidron Healthcare Co-invest II Limited.

Place of completion	St Helier, Jersey JE2 3QA
Date of completion	8 May 2018

Annex: Notification of major holdings (to be filed with the FCA only)
A: Identity of the person subject to the notification obligation
Full name (including legal form for legal entities)		NORDIC CAPITAL VI LIMITED NORDIC CAPITAL VII LIMITED
Contact address (registered office for legal entities)		26 Esplanade, St Helier, Jersey JE2 3QA
E-Mail		Jean.lecreurer@nordiccapital.je
Phone number / Fax number		+ 44 1534 605103
Other useful information (at least legal representative for legal persons)		Contact name: Jean Le Creurer
B: Identity of the notifier, if applicable
Full name
Contact address
E-Mail
Phone number / Fax number
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)
C: Additional information

Please send the completed form together with this annex to the FCA at the following email

address: Majorshareholdings@fca.org.uk. Please send in Microsoft Word format if possible.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEANSPESAPEEF